Mastodawn

Kilian Schober Jan 20, 2023

Plenty of good vaccine news lately, unfortunately not regarding HIV: J&J just declared to discontinue their phase 3 HIV vaccine trial with a mosaic-based Ad26.
https://www.jnj.com/janssen-and-global-partners-to-discontinue-phase-3-mosaico-hiv-vaccine-clinical-trial
https://www.nih.gov/news-events/news-releases/experimental-hiv-vaccine-regimen-safe-ineffective-study-finds

Janssen and Global Partners to Discontinue Phase 3 Mosaico HIV Vaccine Clinical Trial | Johnson & Johnson

Independent, scheduled review of Phase 3 Mosaico study finds investigational vaccine regimen lacks efficacy in preventing HIVNo vaccine-related safety issues identified

Content Lab U.S.